Aachen, Germany & Toronto, Canada, (ots) - Grünenthal, a global leader in pain management and related diseases, and Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, announced today that they have entered into a strategic licensing agreement whereby Apotex will have the exclusive Canadian rights to Qutenza®, a topical, non-systemic, ...
Mountain View (California), Mumbai (India) and Montreal (Canada) (ots) - --News Direct-- CleverTap, a leading global B2B SaaS platform for customer engagement and retention today announced it has signed definitive agreements to raise US$105M in a Series D funding round led by CDPQ, a global investment group who committed US$75M, with participation from IIFL AMC’s Tech Fund, along with existing investors Tiger Global and ...
Montreal, Canada (ots/PRNewswire) - Global digital out of home ad tech leader introduces multiple SSP/Ad Exchange support to its flagship Ad Server Hivestack, the world's largest, independent, programmatic digital out of home (DOOH) ad tech company has opened up its Ad Server to work with multiple SSP/Exchanges with the introduction of a new, unified auction framework that optimizes publisher yield across various sources. ...
MONTREAL, CANADA and LAUSANNE, SWITZERLAND (ots) - Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company and Debiopharm, a swiss-based, global biopharmaceutical company, today announced that they have entered into an exclusive agreement that grants Knight the rights to commercialize Trelstar® (triptorelin) in Canada. ...
Québec, Canada (ots) - GenePOC Inc., member of the Debiopharm Group, announces its third test to be cleared by the FDA, the GenePOC Strep A assay, to be used with the revogene(TM) device. About Group A Streptococcus (GAS) infection GAS is the most common bacterial etiology of pharyngitis accounting for 15 to 30% cases in children and 5 to 20% in adults[1]. In the ...
Québec, Canada (ots) - GenePOC Inc. (GenePOC), a member of the Debiopharm Group(TM), is proud to announce the launch of its 2nd FDA cleared assay in less than 6 months, GenePOC(TM) CDiff, for use on the revogene(TM) instrument. The GenePOC CDiff test targets the toxin B gene of toxigenic C. difficile strains in ...
Québec, Canada (ots) - GenePOC, Inc. (GenePOC), a member of the Debiopharm Group, is proud to announce the launch of its 2nd assay this year, GenePOC(TM) GBS DS[1], for use on the revogene(TM) instrument. GenePOC GBS DS at intrapartum will aid to minimize the risk of GBS transmission from the mother to their ...
Québec, Canada (ots) - GenePOC announces the signing of an exclusive distribution agreement with Cardinal Health to become its commercial partner in the United States. GenePOC, Inc. (GenePOC), a member of the Debiopharm Group, is proud to announce that it has signed an exclusive distribution agreement with Cardinal ...
Québec, Canada and Lausanne, Switzerland (ots) - GenePOC announces it received 510(k) clearance from the US Food and Drug Administration to market its first molecular assay to detect Group B Streptococcus and for the revogene molecular diagnostics instrument. GenePOC, Inc. (GenePOC) a member of the Debiopharm Group is pleased to announce that it has received FDA ...
Québec, Canada/Lausanne, Switzerland (ots) - GenePOC announces the commercialization of its Clostridium difficile and Group B Strep molecular tests in Europe, along with onboarding additional partners to cover the EMEA market GenePOC, Inc. (GenePOC) a member of the Debiopharm Group is proud to announce that it has started the commercialization of its first two CE-IVD marked tests, GenePOC(TM) CDiff and GenePOC(TM) GBS ...
Montreal, Canada (ots) - Consumer expectations complement bank executives' views on the urgency to accelerate digital transformation identified in 2016 CGI Global 1000 outlook CGI (TSX: GIB.A) (NYSE: GIB) today released the findings from its 2016 consumer survey on digital financial services and how well financial ...
Ottawa, Canada (ots/PRNewswire) - CENX (http://cenx.com/), the global leader of orchestrated service management and assurance solutions for physical and virtualized networks, today announced it has successfully interoperated with Ixia, Mitel, and VMware to demonstrate comprehensive real-time assurance of mobile data services for virtual Evolved Packet Core (vEPC). ...
Vancouver, Canada (ots/PRNewswire) - This material is intended for global medical media only. This material is not approved for Canadian journalists or Canadian audiences. For journalistic assessment and preparation before publication. Results from the Perceptions of Control (POC) study showed that people with type ...
Vancouver, Canada (ots/PRNewswire) - This material is intended for global medical media only. This material is not approved for Canadian journalists or Canadian audiences. For journalistic assessment and preparation before publication. Abstracts: 0720-P, 0721-P, 1074-P, 0956-P New data from four analyses[1],[2],[3],[4] demonstrate that post-meal hyperglycaemia (when ...
Vancouver, Canada (ots/PRNewswire) - This material is intended for global medical media only. This material is not approved for Canadian journalists or Canadian audiences. For journalistic assessment and preparation before publication. New findings from a network meta-analysis show that treatment with Victoza® (liraglutide) provides a greater HbA1c reduction and an ...
Ottawa, Canada (ots/PRNewswire) - Services Lifecycle Management Essential to Software-Defined Networks CENX [http://cenx.com ], a global provider of Service Orchestration solutions for software-defined networks, today announced the launch of its Cortx Service Orchestration [http://www.cenx.com/cortx-service-orchestrator ] suite, which brings service agility to networks migrating to Software-Defined Networking (SDN) and ...
Ottawa, Canada (ots/PRNewswire) - The Royal Architectural Institute of Canada (RAIC) Foundation announces the launch of one of the largest architectural prizes in the world - the Moriyama RAIC International Prize. Distinguished Canadian architect Raymond Moriyama established the prize together with the Foundation. To be awarded every two years, the prize consists of CAD $100,000 and a sculpture designed by Canadian ...
Ottawa, Canada (ots/PRNewswire) - Ethernet service orchestration software accelerates build-out of 4G mobile backhaulnetwork CENX announced a multi-million dollar order from a tier one service provider for the company's new Ethernet Lifecycle Manager solution. A new generation software solution focused uniquely on orchestrating Carrier Ethernet transport services, the CENX solution improves Ethernet inventory integrity ...
Blainville, Canada (ots/PRNewswire) - Following the US approval of its morning sickness medication Diclegis by the US Food and Drug Administration (FDA) [http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm347087.htm ], the Canadian pharmaceutical company Duchesnay Inc. ...
Calgary, Canada (ots/PRNewswire) - Transaction Designed to Enhance Shareholder Value By Unlocking Value of the Epigenetics Platform TSX Exchange Symbol: RVX Resverlogix Corp. ("Resverlogix") today announced that its Board of Directors has approved a proposal to spin-out its subsidiary, RVX Therapeutics Inc. ("RVX Therapeutics"), which will focus on innovative drug research and development by leveraging its epigenetics ...